159 related articles for article (PubMed ID: 21172035)
1. Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.
Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
BMC Gastroenterol; 2010 Dec; 10():145. PubMed ID: 21172035
[TBL] [Abstract][Full Text] [Related]
2. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.
El-Chennawi FA; Auf FA; Metwally SS; Mosaad YM; El-Wahab MA; Tawhid ZE
Immunol Invest; 2008; 37(7):661-74. PubMed ID: 18821214
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.
Liu L; Guo W; Zhang J
Minerva Med; 2017 Apr; 108(2):176-184. PubMed ID: 27808488
[TBL] [Abstract][Full Text] [Related]
4. Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis.
Xin YN; Lin ZH; Jiang XJ; Zhan SH; Dong QJ; Wang Q; Xuan SY
World J Gastroenterol; 2011 May; 17(17):2248-54. PubMed ID: 21633537
[TBL] [Abstract][Full Text] [Related]
5. Relationship between HLA-DRB1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients.
Hamed NA; Hano AF; Raouf HA; Gamal M; Eissa M
Egypt J Immunol; 2003; 10(1):17-26. PubMed ID: 15719619
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis.
Yao K; Yang S; Shen J; Zhang R; Li L
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):297-303. PubMed ID: 27535842
[TBL] [Abstract][Full Text] [Related]
7. HLA class II alleles in Chinese patients with hepatocellular carcinoma.
Donaldson PT; Ho S; Williams R; Johnson PJ
Liver; 2001 Apr; 21(2):143-8. PubMed ID: 11318984
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese.
Shi Y; Zhai W; Wang B; Zhao D; Jin H; Wang Y; Zhang J; An H; Fu Z; Zhao K; Lu C
Oncotarget; 2016 Dec; 7(49):80935-80942. PubMed ID: 27821814
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.
Hong X; Yu RB; Sun NX; Wang B; Xu YC; Wu GL
World J Gastroenterol; 2005 Dec; 11(46):7302-7. PubMed ID: 16437632
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1 allele polymorphisms in genetic susceptibility to esophageal carcinoma.
Lin J; Deng CS; Sun J; Zheng XG; Huang X; Zhou Y; Xiong P; Wang YP
World J Gastroenterol; 2003 Mar; 9(3):412-6. PubMed ID: 12632487
[TBL] [Abstract][Full Text] [Related]
11. Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients.
Jin YJ; Shim JH; Chung YH; Kim JA; Choi JG; Park WH; Lee D; Lee YS; Kim SE; Kim SH; Yang SH
J Clin Gastroenterol; 2012; 46(5):420-6. PubMed ID: 22499074
[TBL] [Abstract][Full Text] [Related]
12. Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis.
Yan L; Wang JM; Zeng K
Br J Dermatol; 2012 Oct; 167(4):768-77. PubMed ID: 22564118
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis.
Hajjej A; Almawi WY; Stayoussef M; Arnaiz-Villena A; Hattab L; Hmida S
Immunol Invest; 2019 Feb; 48(2):130-146. PubMed ID: 30004835
[TBL] [Abstract][Full Text] [Related]
15. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis.
Yang YC; Chang TY; Lee YJ; Su TH; Dang CW; Wu CC; Liu HF; Chu CC; Lin M
Hum Immunol; 2006; 67(4-5):331-40. PubMed ID: 16720214
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
[TBL] [Abstract][Full Text] [Related]
17. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a histocompatibility antigen related to hepatitis B virus in patients with hepatocellular carcinoma in the western Brazilian Amazon.
Chalub SR; da Silva RM; da Silva AP; de Aquino PF; Sadahiro A; Kalil AN
Genet Mol Res; 2013 Apr; 12(2):1336-46. PubMed ID: 23661457
[TBL] [Abstract][Full Text] [Related]
19. HLA class II polymorphism in Latin American patients with multiple sclerosis.
Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM
Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus.
Castaño-Rodríguez N; Diaz-Gallo LM; Pineda-Tamayo R; Rojas-Villarraga A; Anaya JM
Autoimmun Rev; 2008 Feb; 7(4):322-30. PubMed ID: 18295738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
